These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11945163)

  • 21. Application of artificial neural networks in the design of controlled release drug delivery systems.
    Sun Y; Peng Y; Chen Y; Shukla AJ
    Adv Drug Deliv Rev; 2003 Sep; 55(9):1201-15. PubMed ID: 12954199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advantages of Artificial Neural Networks (ANNs) as alternative modelling technique for data sets showing non-linear relationships using data from a galenical study on a solid dosage form.
    Bourquin J; Schmidli H; van Hoogevest P; Leuenberger H
    Eur J Pharm Sci; 1998 Dec; 7(1):5-16. PubMed ID: 9845773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy.
    Wang D; Larder B; Revell A; Montaner J; Harrigan R; De Wolf F; Lange J; Wegner S; Ruiz L; Pérez-Elías MJ; Emery S; Gatell J; D'Arminio Monforte A; Torti C; Zazzi M; Lane C
    Artif Intell Med; 2009 Sep; 47(1):63-74. PubMed ID: 19524413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applications of Artificial Neural Networks in integrated water management: fiction or future?
    Schulze FH; Wolf H; Jansen HW; van der Veer P
    Water Sci Technol; 2005; 52(9):21-31. PubMed ID: 16445170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new approach to dose estimation and in-phantom figure of merit measurement in BNCT by using artificial neural networks.
    Ahangari R; Afarideh H
    Australas Phys Eng Sci Med; 2011 Dec; 34(4):467-79. PubMed ID: 22042720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neural network modeling for estimation of the aqueous solubility of structurally related drugs.
    Huuskonen J; Salo M; Taskinen J
    J Pharm Sci; 1997 Apr; 86(4):450-4. PubMed ID: 9109047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Machine learning based sample extraction for automatic speech recognition using dialectal Assamese speech.
    Agarwalla S; Sarma KK
    Neural Netw; 2016 Jun; 78():97-111. PubMed ID: 26783204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Artificial neural networks in analysis of indinavir and its degradation products retention.
    Jancić-Stojanović B; Ivanović D; Malenović A; Medenica M
    Talanta; 2009 Apr; 78(1):107-12. PubMed ID: 19174211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Artificial neural network parameters optimization software and its application in the design of sustained release tablets].
    Zhang XY; Chen DW; Jin J; Lu W
    Yao Xue Xue Bao; 2009 Oct; 44(10):1159-64. PubMed ID: 20055142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
    Ventura C; Latino DA; Martins F
    Eur J Med Chem; 2013; 70():831-45. PubMed ID: 24246731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Methods of artificial intelligence: a new trend in pharmacy].
    Dohnal V; Kuca K; Jun D
    Ceska Slov Farm; 2005 Jul; 54(4):163-7. PubMed ID: 16124196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artificial neural networks in laboratory medicine and medical outcome prediction.
    Tafeit E; Reibnegger G
    Clin Chem Lab Med; 1999 Sep; 37(9):845-53. PubMed ID: 10596951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uncertainty in the output of artificial neural networks.
    Jiang Y
    IEEE Trans Med Imaging; 2003 Jul; 22(7):913-21. PubMed ID: 12906245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Automated quantification of human brain metabolites by artificial neural network analysis from in vivo single-voxel 1H NMR spectra.
    Kaartinen J; Mierisová S; Oja JM; Usenius JP; Kauppinen RA; Hiltunen Y
    J Magn Reson; 1998 Sep; 134(1):176-9. PubMed ID: 9740747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generating rules with predicates, terms and variables from the pruned neural networks.
    Nayak R
    Neural Netw; 2009 May; 22(4):405-14. PubMed ID: 19269778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Artificial neural network as a novel method to optimize pharmaceutical formulations.
    Takayama K; Fujikawa M; Nagai T
    Pharm Res; 1999 Jan; 16(1):1-6. PubMed ID: 9950271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The development of artificial neural networks to predict virological response to combination HIV therapy.
    Larder B; Wang D; Revell A; Montaner J; Harrigan R; De Wolf F; Lange J; Wegner S; Ruiz L; Pérez-Elías MJ; Emery S; Gatell J; Monforte AD; Torti C; Zazzi M; Lane C
    Antivir Ther; 2007; 12(1):15-24. PubMed ID: 17503743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Artificial Neural Networks in Computer-Aided Drug Design: An Overview of Recent Advances.
    Cheirdaris DG
    Adv Exp Med Biol; 2020; 1194():115-125. PubMed ID: 32468528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Science of the science, drug discovery and artificial neural networks.
    Patel J
    Curr Drug Discov Technol; 2013 Mar; 10(1):2-7. PubMed ID: 22725688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neural network based optimization of drug formulations.
    Takayama K; Fujikawa M; Obata Y; Morishita M
    Adv Drug Deliv Rev; 2003 Sep; 55(9):1217-31. PubMed ID: 12954200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.